- Stocks
- Healthcare
- NASDAQ: MDWD

Price (delayed)

$17.61

Market cap

$162.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.38

Enterprise value

$133.51M

mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe

The net income has plunged by 90% from the previous quarter but it has grown by 35% YoY

The EPS has dropped by 84% since the previous quarter but it has surged by 60% year-on-year

MDWD's gross profit has dropped by 73% year-on-year and by 6% since the previous quarter

The company's gross margin has shrunk by 65% YoY and by 12% QoQ

What are the main financial stats of MDWD

Market
Valuations
Earnings

Shares outstanding

9.23M

Market cap

$162.61M

Enterprise value

$133.51M

Price to earnings (P/E)

N/A

Price to book (P/B)

7

Price to sales (P/S)

8.19

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.73

Revenue

$19.85M

EBIT

-$8.83M

EBITDA

-$7.46M

Free cash flow

-$21.94M

Per share
Balance sheet
Liquidity

EPS

-$1.38

Free cash flow per share

-$2.38

Book value per share

$2.52

Revenue per share

$2.15

TBVPS

$6.74

Total assets

$62.38M

Total liabilities

$39.18M

Debt

$6.47M

Equity

$23.2M

Working capital

$21.86M

Debt to equity

0.28

Current ratio

1.98

Quick ratio

1.84

Net debt/EBITDA

3.9

Margins
Efficiency
Dividend

EBITDA margin

-37.6%

Gross margin

16.9%

Net margin

-64.2%

Operating margin

-74.9%

Return on assets

-19.6%

Return on equity

-41.5%

Return on invested capital

-29.5%

Return on capital employed

-22.1%

Return on sales

-44.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the MediWound stock price performed over time

Intraday

-2.44%

1 week

7.71%

1 month

-16.78%

1 year

97.42%

YTD

73.16%

QTD

13.47%

How have MediWound's revenue and profit performed over time

Revenue

$19.85M

Gross profit

$3.36M

Operating income

-$14.87M

Net income

-$12.75M

Gross margin

16.9%

Net margin

-64.2%

The company's operating margin has shrunk by 114% YoY but it rose by 10% QoQ

The net income has plunged by 90% from the previous quarter but it has grown by 35% YoY

MediWound's net margin has shrunk by 79% QoQ but it has increased by 16% YoY

MDWD's gross profit has dropped by 73% year-on-year and by 6% since the previous quarter

What is MediWound's growth rate over time

What is MediWound stock price valuation

P/E

N/A

P/B

7

P/S

8.19

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.73

The EPS has dropped by 84% since the previous quarter but it has surged by 60% year-on-year

MDWD's P/B is 105% above its last 4 quarters average of 3.5 but 44% below its 5-year quarterly average of 12.9

The equity has declined by 30% year-on-year and by 27% since the previous quarter

The P/S is 121% higher than the 5-year quarterly average of 3.8 and 75% higher than the last 4 quarters average of 4.8

MediWound's revenue has decreased by 23% YoY but it has increased by 6% from the previous quarter

How efficient is MediWound business performance

MDWD's ROE has shrunk by 105% QoQ but it has soared by 77% YoY

The ROA has plunged by 94% from the previous quarter but it has soared by 58% YoY

MDWD's ROIC has soared by 92% year-on-year and by 53% since the previous quarter

The return on sales has increased by 46% since the previous quarter but it has declined by 22% year-on-year

What is MDWD's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for MDWD.

How did MediWound financials performed over time

The company's total assets is 59% higher than its total liabilities

The company's quick ratio fell by 29% QoQ and by 28% YoY

MDWD's current ratio is down by 28% since the previous quarter and by 25% year-on-year

MediWound's debt is 72% lower than its equity

MediWound's debt to equity has increased by 40% QoQ

The equity has declined by 30% year-on-year and by 27% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.